1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02898, 97-24-51, U10CA025224, CDR0000067033, NCCTG-972451, NCT00003869
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 or over Sponsor: NCI Protocol IDs: WCCC-CO-9397, NCI-T93-0193C, T93-0193
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-97-C-0059C, NCI-T96-0053, T96-0053
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0012, NCI-T97-0112, T97-0112, NCT00019461
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: NABTT-9904 CDR0000067378, U01CA062475, NABTT-9904, JHOC-NABTT-9904, NCT00004146
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-4896, NCT00005045, E4896
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02364, CLB-69901, U10CA031946, CDR0000068317, CALGB-69901, NCT00006486
|
|
8.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02265, UCCRC-9019, NCI-T97-0086, CDR0000066129, T97-0086, NCT00003249
|
|
9.
|
Phase: Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: NCI-92-C-0054P, NCI-MB-281, NCI-T91-0170N, T91-0170
|
|
10.
|
Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, NIH WGMCC Protocol IDs: 950015, 95-C-0015, NCI-CPB-334, NCI-T94-0006N, CDR0000063881, NCI-95-C-0015, T94-0006, NCT00019019
|